Have a personal or library account? Click to login

First Experience and the Effectiveness of Immunomodulating Treatment in Inflammatory Demyelinating CNS Diseases: Analysis of Nine Patients / Imūnmodulējošās Terapijas Efektivitāte Centrālās Nervu Sistēmas Iekaisīgu Saslimšanu Gadījumos: Deviņu Pacientu Analīze

Open Access
|Apr 2016

References

  1. Cortese, I., Chaudhry, V., So, Y. T., Cantor, F., Cornblath, D. R., Rae-Grant, A. (2011). Evidence-based guideline update: plasmapheresis in neurologic disorders: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology, 76 (3), 294-300.10.1212/WNL.0b013e318207b1f6303439521242498
  2. Hughes, R. A., Swan, A. V., Raphael, J. C., Annane, D., van Koningsveld, R., van Doorn, P. (2007). Immunotherapy for Guillain-Barre syndrome: A systematic review. Brain, 130 (pt 9), 2245-2257.10.1093/brain/awm00417337484
  3. Ibrahim, R. B., Balogun, R. A. (2012). Medications in patients treated with therapeutic plasma exchange: Prescription dosage, timing, and drug overdose.10.1111/j.1525-139X.2011.01030.x22321259
  4. Seminars in Dialysis, 25 (2), 176-189.
  5. Kaya, E., Keklik, M., Sencan, M., Yilmaz, M., Keskin, A., Kiki, I., Erkurt, M. A., Sivgin, S., Korkmaz, S., Okan, V., Došu, M. H., Unal, A., Cetin, M., Altuntaº, F., Ilhan, O. (2013). Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis. Transfus.10.1016/j.transci.2013.04.01523619327
  6. Apher. Sci., 48 (3), 349-352.
  7. Keegan, M., Pineda, A. A., McClelland, R. L., Darby, C. H., Rodriguez, M., Weinshenker, B. G. (2002). Plasma exchange for severe attacks of CNS demyelination: Predictors of response. Neurology, 58 (1), 143-146.10.1212/WNL.58.1.143
  8. Keller, A. J., Urbaniak, S. J. (1978). Intensive plasma exchange on the cell separator: Effects on serum immunoglobulins and complement components.10.1111/j.1365-2141.1978.tb01078.x646951
  9. Brit. J. Haematol., 38 (4), 531-540.
  10. Kes, P., Basiã-Kes, V., Basiã-Jukiã, N., Demarin, V. (2012). Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice. Acta Clin. Croat., 51 (1), 137-153.
  11. Lassmann, H., Brück, W., Lucchinetti, C. F. (2007). The immunopathology of multiple sclerosis: An overview. Brain Pathol., 17 (2), 210-218.10.1111/j.1750-3639.2007.00064.x809558217388952
  12. Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., Weinshenker, B. G. (2004). A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet, 364 (9451), 2106-2112.
  13. Miyamoto, K., Kusunoki, S. (2009). Intermittent plasmapheresis prevents recurrence in neuromyelitis optica. Ther. Apher. Dial., 13 (6), 505-508.10.1111/j.1744-9987.2009.00780.x19954473
  14. Munemoto, M., Otaki, Y., Kasama, S., Nanami, M., Tokuyama, M., Yahiro, M., Hasuike, Y., Kuragano, T., Yoshikawa, H., Nonoguchi, H., Nakanishi, T. (2011). Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis. J. Clin.10.1016/j.jocn.2010.07.14121315606
  15. Neurosci., 18 (4), 478-480.
  16. Polman, C., Reingold, S., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F. D., Montalban, X., O’Connor, P., Sandberg-Wollheim, M., Thompson, A. J., Waubant, E., Weinshenker, B., Wolinsky, S. (2011). Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann. Neurol., 69 (2), 292-302.10.1002/ana.22366308450721387374
  17. Ruprecht, K., Klinker, E., Dintelmann, T., Rieckmann, P., Gold, R. (2004).
  18. Plasma exchange for severe optic neuritis: Treatment of 10 patients. Neurology, 63 (6), 1081-1083.10.1212/01.WNL.0000138437.99046.6B
  19. Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sorensen, P. S., Hemmer, B. (2010).
  20. EFNS guidelines on diagnosis and management of Neuromyelitis optica.
  21. Eur. J. Neurol., 17 (8), 1019-1032.
  22. Szczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Weinstein, R., Shaz, B. H. (2010). Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J. Clin. Apher., 25 (3), 83-177.10.1002/jca.20240
  23. Sellebjerg, F., Barnes, D., Filippini, G., Midgard, R., Montalban, X., Rieckmann, P., Selmaj, K., Visser, L. H., Soelberg, S¸rensen, P. (2011).
  24. Acute relapses of multiple sclerosis. In: Gilhus, N. E., Barnes, M. P., Brainin, M. (eds.). European Handbook of Neurological Management.
  25. Vol. 1. 2nd edn. Blackwell Publishing Ltd., pp. 411-419.
  26. Watanabe, S., Nakashima, I., Misu, T., Miyazawa, I., Shiga, Y., Fujihara, K., Itoyama, Y. (2007). Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult. Scler., 13 (1), 128-132.10.1177/1352458506071174
  27. Weinshenker, B. G., O'Brien, P. C., Petterson, T. M., Noseworthy, J. H., Lucchinetti, C. F., Dodick, D. W., Pineda, A. A., Stevens, L. N., Rodriguez, M. (1999). A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol., 46 (6), 878-886.10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q
  28. Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., Weinshenker, B. G. (2006). Revised diagnostic criteria for neuromyelitis optica. Neurology, 66 (10), 1485-1489.10.1212/01.wnl.0000216139.44259.74
  29. Yilmaz, A. A., Can, O. S., Oral, M., Unal, N., Ayyildiz, E., Ilhan, O., Tulunay, M. (2011). Therapeutic plasma exchange in an intensive care unit (ICU): A 10-year, single-center experience. Transfus. Apher. Sci., 45 (2), 161-166.10.1016/j.transci.2011.04.008
  30. Yoshida, H., Ando, A., Sho, K., Akioka, M., Kawai, E., Arai, E., Nishimura, T., Shinde, A., Masaki, H., Takahashi, K., Takagi, M., Tanaka, K. (2010).
  31. Anti-aquaporin-4 antibody-positive optic neuritis treated with double-filtration plasmapheresis. J. Ocul. Pharmacol. Ther., 26 (4), 381-385. 10.1089/jop.2009.0150
DOI: https://doi.org/10.1515/prolas-2015-0041 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 269 - 273
Submitted on: Sep 1, 2015
Published on: Apr 12, 2016
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2016 Lana Vainšteine, Andrejs Kostiks, Guntis Karelis, Viktorija Ķēniņa, Natalja Zlobina, Angelika Krūmiņa, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.